GSK Aktie
23,36
EUR
-0,29
EUR
-1,23
%
21,11
CHF
+0,05
CHF
+0,24
%
Werbung
GSK Aktie Analyse
| 12.03.26 | GSK Underweight | Barclays Capital | |
| 02.03.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 26.02.26 | GSK Buy | Jefferies & Company Inc. | |
| 26.02.26 | GSK Underweight | Barclays Capital | |
| 26.02.26 | GSK Neutral | UBS AG | |
| 25.02.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 25.02.26 | GSK Underweight | Barclays Capital | |
| 20.02.26 | GSK Underweight | Barclays Capital | |
|
Werbung
|
|||
| 19.02.26 | GSK Hold | Deutsche Bank AG | |
| 17.02.26 | GSK Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 13.02.26 | GSK Buy | Jefferies & Company Inc. | |
| 06.02.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.02.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.02.26 | GSK Hold | Deutsche Bank AG | |
| 04.02.26 | GSK Buy | Jefferies & Company Inc. | |
| 27.01.26 | GSK Hold | Deutsche Bank AG | |
| 22.01.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 21.01.26 | GSK Neutral | UBS AG | |
| 20.01.26 | GSK Underweight | Barclays Capital | |
| 16.01.26 | GSK Neutral | UBS AG | |
| 16.01.26 | GSK Hold | Deutsche Bank AG | |
| 15.01.26 | GSK Underweight | Barclays Capital | |
| 14.01.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 08.01.26 | GSK Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.26 | GSK Hold | Deutsche Bank AG | |
| 07.01.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 07.01.26 | GSK Buy | Jefferies & Company Inc. | |
| 07.01.26 | GSK Underweight | Barclays Capital | |
| 23.12.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 17.12.25 | GSK Neutral | Goldman Sachs Group Inc. | |
| 16.12.25 | GSK Hold | Deutsche Bank AG | |
| 09.12.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 08.12.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 04.12.25 | GSK Neutral | UBS AG | |
| 25.11.25 | GSK Hold | Deutsche Bank AG | |
| 25.11.25 | GSK Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.11.25 | GSK Buy | Jefferies & Company Inc. | |
| 07.11.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.11.25 | GSK Outperform | Bernstein Research | |
| 04.11.25 | GSK Hold | Deutsche Bank AG | |
| 31.10.25 | GSK Buy | Jefferies & Company Inc. | |
| 30.10.25 | GSK Halten | DZ BANK | |
| 30.10.25 | GSK Hold | Deutsche Bank AG | |
| 30.10.25 | GSK Neutral | UBS AG | |
| 29.10.25 | GSK Outperform | Bernstein Research | |
| 29.10.25 | GSK Neutral | UBS AG | |
| 29.10.25 | GSK Buy | Jefferies & Company Inc. | |
| 29.10.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 27.10.25 | GSK Hold | Deutsche Bank AG | |
| 27.10.25 | GSK Buy | Jefferies & Company Inc. | |
Werbung
Werbung